CACI International
CACI NYSE Diversified Support Services Financials FY2017βFY2026
CACI International's revenue rose 10.9% to $9.6 billion in fiscal 2026. Its operating margin was 9.6%, up from 8.9% a year earlier. Free cash flow was $780 million, up 62.0%. It paid out $17 million in dividends and buybacks, 2% of free cash flow. The diluted share count fell 1.0%.
What CACI International does
No business description yet.
- Legal name
- CACI International Inc
- Fiscal year ends
- June 30, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-054195
0000016058
Revenue and margins
CACI International had $9.6B of revenue in fiscal 2026, up 10.9% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 15.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $780M in fiscal 2026, 8.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CACI International returned $17.1M to shareholders in fiscal 2026, 2% of free cash flow. The diluted share count fell 1.0%.
Value CACI International yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.7B and divides by 22.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 26.0x Β· peers 14.9x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably CACI International can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $115M | $116M | $134M | $106M | $192M |
| Debt incl. finance leases | $1.7B | $1.7B | $1.5B | $2.9B | $4.9B |
| Net debt / EBITDA | 2.6x | 2.2x | 2.0x | 3.4x | 4.7x |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.8x | 1.1x |
| Interest coverage | 11.9x | 6.8x | 6.2x | 4.8x | 4.3x |
| Current ratio | 1.2x | 1.2x | 1.3x | 1.5x | 1.5x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.4x | 1.4x |
| Total assets | $6.6B | $6.6B | $6.8B | $8.6B | $11.8B |
| Total liabilities | $3.6B | $3.4B | $3.3B | $4.8B | $7.4B |
| Shareholders' equity | $3.1B | $3.2B | $3.5B | $3.9B | $4.5B |
| Net debt (β = net cash) | $1.6B | $1.6B | $1.4B | $2.8B | $4.7B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.3M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Susan M. GordonDirector | Sold | 264 | $500.38 | $0.1M | Form 4 |
| Mar 11, 2026 | Debora A PlunkettDirector | Sold | 220 | $603.30 | $0.1M | Form 4 |
| Feb 10, 2026 | Koegel J William JREVP, General Counsel | Sold | 2,000 | $615.06 | $1.2M | Form 4 |
| Dec 10, 2025 | William L JewsDirector | Sold | 3,000 | $585.82 | $1.8M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 8 | 7 / 8 | 5 / 8 |
| Accruals ratio | β1.2% | β0.6% | β3.4% |
| Altman Z'' | 4.15 | 3.72 | 3.06 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| CACI International CACI | $14.1B | 10.9% | 9.6% | 8.2% | 8.8% | 26.0x | 5 | |
| Cintas CTAS | $90.6B | 8.9% | 23.1% | 16.7% | 31.7% | 44.2x | 8 | Compare β |
| KBR KBR | $5.0B | 1.0% | 10.0% | 6.6% | 15.8% | 11.8x | 7 | Compare β |
| Science Applications Intl SAIC | $6.2B | β2.9% | 7.2% | 8.0% | 12.8% | 17.0x | 7 | Compare β |
| Leidos LDOS | $17.1B | 3.1% | 12.3% | 9.5% | 19.3% | 12.7x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.4B | $4.5B | $5.0B | $5.7B | $6.0B | $6.2B | $6.7B | $7.7B | $8.6B | $9.6B |
| Gross profit | $297M | $341M | $378M | β | β | β | β | β | β | β |
| Operating income | $297M | $341M | $378M | $458M | $540M | $496M | $568M | $650M | $764M | $920M |
| Interest expense | $48.6M | $42.0M | $50.0M | $56.1M | $39.8M | $41.8M | $83.9M | $105M | $159M | $216M |
| Pretax income | $249M | $299M | $328M | $402M | $500M | $455M | $484M | $545M | $605M | $704M |
| Income tax | $84.9M | β$2.5M | $62.3M | $80.2M | $42.2M | $87.8M | $98.9M | $125M | $106M | $169M |
| Net income | $164M | $301M | $266M | $322M | $457M | $367M | $385M | $420M | $500M | $536M |
| Diluted EPS | $6.53 | $11.93 | $10.46 | $12.61 | $18.30 | $15.49 | $16.43 | $18.60 | $22.32 | $24.16 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $281M | $322M | $555M | $519M | $592M | $746M | $388M | $497M | $547M | $887M |
| Capital expenditure | $43.3M | $41.6M | $47.9M | $72.3M | $73.1M | $74.6M | $63.7M | $63.7M | $65.6M | $107M |
| Free cash flow | $238M | $280M | $507M | $446M | $519M | $671M | $324M | $434M | $481M | $780M |
| Depreciation and amortization | $71.8M | $72.2M | $85.9M | $111M | $125M | $135M | $142M | $68.4M | $70.5M | $77.6M |
| Stock-based compensation | $21.9M | $23.6M | $25.3M | $29.3M | $30.5M | $31.7M | $39.6M | $53.9M | $60.2M | $79.5M |
| Acquisitions | $7.3M | $76.9M | $1.1B | $106M | $356M | $616M | $14.5M | $90.2M | $1.7B | $2.6B |
| Share buybacks | $4.4M | $5.1M | $5.8M | $7.8M | $509M | $9.8M | $273M | $162M | $169M | $17.1M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $4.4M | $5.1M | $5.8M | $7.8M | $509M | $9.8M | $273M | $161M | $169M | $17.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $65.5M | $66.2M | $72.0M | $107M | $88.0M | $115M | $116M | $134M | $106M | $192M |
| Total debt | $1.2B | $1.1B | $1.7B | $1.4B | $1.7B | $1.7B | $1.7B | $1.5B | $2.9B | $4.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $880M | $931M | $1.0B | $1.1B | $1.3B | $1.2B | $1.2B | $1.4B | $1.8B | $2.3B |
| Current liabilities | $527M | $539M | $692M | $769M | $885M | $1.0B | $994M | $1.1B | $1.2B | $1.5B |
| Inventory | $0.0M | $25.9M | $47.2M | $65.2M | $79.7M | $99.4M | $131M | $118M | $129M | $181M |
| Property and equipment, net | $91.7M | $101M | $150M | $171M | $190M | $206M | $200M | $195M | $212M | $397M |
| Total assets | $3.9B | $4.0B | $5.1B | $5.5B | $6.2B | $6.6B | $6.6B | $6.8B | $8.6B | $11.8B |
| Total liabilities | $2.1B | $1.9B | $2.7B | $2.9B | $3.5B | $3.6B | $3.4B | $3.3B | $4.8B | $7.4B |
| Shareholders' equity | $1.8B | $2.1B | $2.4B | $2.7B | $2.7B | $3.1B | $3.2B | $3.5B | $3.9B | $4.5B |
| Margins | ||||||||||
| Gross margin | 6.8% | 7.6% | 7.6% | β | β | β | β | β | β | β |
| Operating margin | 6.8% | 7.6% | 7.6% | 8.0% | 8.9% | 8.0% | 8.5% | 8.5% | 8.9% | 9.6% |
| EBITDA margin | 8.5% | 9.2% | 9.3% | 9.9% | 11.0% | 10.2% | 10.6% | 9.4% | 9.7% | 10.4% |
| Net margin | 3.8% | 6.7% | 5.3% | 5.6% | 7.6% | 5.9% | 5.7% | 5.5% | 5.8% | 5.6% |
| FCF margin | 5.5% | 6.3% | 10.2% | 7.8% | 8.6% | 10.8% | 4.8% | 5.7% | 5.6% | 8.2% |
| Returns | ||||||||||
| Return on capital | 6.6% | 11.2% | 8.7% | 9.3% | 11.9% | 8.9% | 9.5% | 10.3% | 10.9% | 8.8% |
| Return on capital employed | 8.7% | 9.9% | 9.6% | 10.0% | 10.7% | 9.1% | 10.1% | 11.5% | 11.6% | 10.4% |
| Return on equity | 9.6% | 15.4% | 11.9% | 12.8% | 17.2% | 12.8% | 12.3% | 12.5% | 13.5% | 12.8% |
| Return on assets | 4.1% | 7.6% | 5.8% | 6.1% | 7.8% | 5.7% | 5.8% | 6.3% | 6.5% | 5.2% |
| Growth | ||||||||||
| Revenue growth | 16.3% | 2.6% | 11.6% | 14.7% | 5.7% | 2.6% | 8.1% | 14.3% | 12.6% | 10.9% |
| Net income growth | 14.6% | 84.0% | β11.8% | 21.0% | 42.3% | β19.8% | 4.9% | 9.2% | 19.0% | 7.2% |
| EPS growth | 13.4% | 82.7% | β12.3% | 20.6% | 45.1% | β15.4% | 6.1% | 13.2% | 20.0% | 8.2% |
| FCF growth | 7.3% | 17.6% | 81.3% | β12.0% | 16.3% | 29.3% | β51.7% | 33.7% | 11.0% | 62.0% |
| Share count change | 1.1% | 0.7% | 0.6% | 0.4% | β1.9% | β5.3% | β1.1% | β3.6% | β0.8% | β1.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.2x | 2.4x | 3.4x | 2.3x | 2.5x | 2.6x | 2.2x | 2.0x | 3.4x | 4.7x |
| Debt / equity | 0.7x | 0.5x | 0.7x | 0.5x | 0.7x | 0.6x | 0.5x | 0.4x | 0.8x | 1.1x |
| Interest coverage | 6.1x | 8.1x | 7.6x | 8.2x | 13.5x | 11.9x | 6.8x | 6.2x | 4.8x | 4.3x |
| Current ratio | 1.7x | 1.7x | 1.5x | 1.4x | 1.5x | 1.2x | 1.2x | 1.3x | 1.5x | 1.5x |
| Quick ratio | 1.7x | 1.7x | 1.4x | 1.3x | 1.4x | 1.1x | 1.1x | 1.2x | 1.4x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 0.9% | 1.0% | 1.3% | 1.2% | 1.2% | 1.0% | 0.8% | 0.8% | 1.1% |
| Stock comp / revenue | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.7% | 0.7% | 0.8% |
| Payouts / FCF | 1.8% | 1.8% | 1.2% | 1.8% | 98.1% | 1.5% | 84.2% | 37.2% | 35.0% | 2.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 8.0 | 4.0 | 4.0 | 6.0 | 5.0 | 7.0 | 8.0 | 7.0 | 5.0 |
| Altman Z'' | 3.5 | 4.1 | 3.4 | 3.5 | 3.5 | 3.3 | 3.7 | 4.2 | 3.7 | 3.1 |
| Accruals ratio | β3.0% | β0.5% | β6.4% | β3.7% | β2.3% | β5.9% | β0.1% | β1.2% | β0.6% | β3.4% |
Source: SEC EDGAR XBRL filings (CIK 0000016058). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.